Anna D. Louie

565 total citations
16 papers, 217 citations indexed

About

Anna D. Louie is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Anna D. Louie has authored 16 papers receiving a total of 217 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Anna D. Louie's work include Cancer Immunotherapy and Biomarkers (5 papers), Cancer Genomics and Diagnostics (3 papers) and Wnt/β-catenin signaling in development and cancer (3 papers). Anna D. Louie is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Cancer Genomics and Diagnostics (3 papers) and Wnt/β-catenin signaling in development and cancer (3 papers). Anna D. Louie collaborates with scholars based in United States, Italy and Taiwan. Anna D. Louie's co-authors include Wafik S. El‐Deiry, Lanlan Zhou, Kelsey E. Huntington, Lindsey Carlsen, Isacco Ferrarini, Zhijie Liu, Wei‐Ting Chao, Thomas J. Miner, Rohit R. Jadhav and Aaron M. Horning and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Anna D. Louie

13 papers receiving 214 citations

Peers

Countries citing papers authored by Anna D. Louie

Since Specialization

Citations

This map shows the geographic impact of Anna D. Louie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna D. Louie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna D. Louie more than expected).

Fields of papers citing papers by Anna D. Louie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna D. Louie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna D. Louie. The network helps show where Anna D. Louie may publish in the future.

Co-authorship network of co-authors of Anna D. Louie

This figure shows the co-authorship network connecting the top 25 collaborators of Anna D. Louie. A scholar is included among the top collaborators of Anna D. Louie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna D. Louie. Anna D. Louie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	TRAIL receptor agonist TLY012 in combination with PD-1 inhibition promotes tumor regression in an immune-competent mouse model of pancreatic ductal adenocarcinoma 2025 ·American Journal of Cancer Research ·Anna D. Louie	1
2	Use of photon-counting CT and three-dimensional printing for an intra-thoracic retained ballistic fragment in a 9-year-old 2025 ·Pediatric Radiology ·(unknown), (unknown), (unknown), (unknown), (unknown), Anna D. Louie, Douglas M. Overbey, (unknown), Elisabeth T. Tracy	1
3	Comparison of survival outcomes for patients with Stage III vs de novo Stage IV breast cancer 2025 ·Cancer ·Michael S. Lee, Samantha M. Thomas, Anna D. Louie, Laura H. Rosenberger, (unknown), Gayle DiLalla, (unknown), Ton Wang, (unknown), E. Shelley Hwang, Jennifer K. Plichta	0
4	GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer 2023 ·International Journal of Molecular Sciences ·Kelsey E. Huntington, Anna D. Louie, (unknown), Christoph Schorl, Shaolei Lu, David Silverberg, Daniel Newhouse, Zhijin Wu, Lanlan Zhou, (unknown), Francis J. Giles, Mark S. Dooner, Benedito A. Carneiro, Wafik S. El‐Deiry	11
5	GSK-3 inhibitor elraglusib (9-ING-41) to enhance tumor-infiltrating immune cell activation in tumor biopsies and synergize with anti-PD-L1 in a murine model of colorectal cancer. 2023 ·Journal of Clinical Oncology ·Wafik S. El‐Deiry, Kelsey E. Huntington, Anna D. Louie, (unknown), (unknown), Shaolei Lu, David Silverberg, Daniel Newhouse, Zhijin Wu, Lanlan Zhou, (unknown), (unknown), Francis J. Giles, Mark S. Dooner, Benedito A. Carneiro	0
6	Colorectal cancer extracellular acidosis decreases immune cell killing and is partially ameliorated by pH-modulating agents that modify tumor cell cytokine profiles. 2022 ·PubMed ·Kelsey E. Huntington, Anna D. Louie, (unknown), Attila A. Seyhan, Aaron Maxwell, Wafik S. El‐Deiry	13
7	Abstract 5607: Combining PD-1 inhibition with the TRAIL receptor agonist TLY012 promotes pancreatic ductal adenocarcinoma tumor regression in an immunocompetent mouse model 2022 ·Cancer Research ·Anna D. Louie, Kelsey E. Huntington, Young Lee, (unknown), (unknown), Seulki Lee, Wafik S. El‐Deiry	0
8	Abstract 4166: Small-molecule inhibition of glycogen synthase kinase-3 (GSK-3) increases the efficacy of anti-PD-L1 therapy in a murine model of microsatellite stable colorectal cancer (CRC); Therapeutic response correlates with T cell ratios and serum cytokine profiles in mice 2022 ·Cancer Research ·Kelsey E. Huntington, Anna D. Louie, (unknown), Benedito A. Carneiro, Wafik S. El‐Deiry	2
9	ONC212 is a Novel Mitocan Acting Synergistically with Glycolysis Inhibition in Pancreatic Cancer 2021 ·Molecular Cancer Therapeutics ·Isacco Ferrarini, Anna D. Louie, Lanlan Zhou, Wafik S. El‐Deiry	28
10	Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma 2021 ·Frontiers in Pharmacology ·Alexander G. Raufi, (unknown), Lindsey Carlsen, (unknown), (unknown), Shengliang Zhang, Xiaobing Tian, Anna D. Louie, Lanlan Zhou, Attila A. Seyhan, Wafik S. El‐Deiry	9
11	Integrating Molecular Biomarker Inputs Into Development and Use of Clinical Cancer Therapeutics 2021 ·Frontiers in Pharmacology ·Anna D. Louie, Kelsey E. Huntington, Lindsey Carlsen, Lanlan Zhou, Wafik S. El‐Deiry	29
12	Palliative surgery and the surgeon’s role in the palliative care team: a review 2021 ·Annals of Palliative Medicine ·Anna D. Louie, Thomas J. Miner	7
13	Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients infected with SARS-CoV-2 2021 ·eLife ·Kelsey E. Huntington, Anna D. Louie, Chun Geun Lee, Jack A. Elias, Eric A. Ross, Wafik S. El‐Deiry	19
14	Providing Appropriate Pancreatic Cancer Care for People Experiencing Homelessness: A Surgical Perspective 2021 ·American Society of Clinical Oncology Educational Book ·Anna D. Louie, (unknown), (unknown), (unknown), (unknown), (unknown), Thomas J. Miner	8
15	A high-throughput customized cytokinome screen of colon cancer cell responses to small-molecule oncology drugs 2021 ·Oncotarget ·Kelsey E. Huntington, Anna D. Louie, Lanlan Zhou, Wafik S. El‐Deiry	8
16	Single-Cell RNA-seq Reveals a Subpopulation of Prostate Cancer Cells with Enhanced Cell-Cycle–Related Transcription and Attenuated Androgen Response 2017 ·Cancer Research ·Aaron M. Horning, Yao Wang, (unknown), Anna D. Louie, Rohit R. Jadhav, (unknown), Chiou-Miin Wang, Chun-Lin Lin, Nameer B. Kirma, Michael A. Liss, Addanki P. Kumar, (unknown), Zhijie Liu, Wei‐Ting Chao, Qianben Wang, Victor X. Jin, Chun‐Liang Chen, Tim H.‐M. Huang	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact